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ABSTRACT Despite differences in the pathogenesis and host range of alphaherpesvi-
ruses, many stages of their morphogenesis are thought to be conserved. Here, an ultra-
structural study of bovine herpesvirus 1 (BoHV-1) envelopment revealed proﬁles similar
to those previously found for herpes simplex virus 1 (HSV-1), with BoHV-1 capsids associ-
ating with endocytic tubules. Consistent with the similarity of their genomes and envel-
opment strategies, the proteomic compositions of BoHV-1 and HSV-1 virions were also
comparable. However, BoHV-1 morphogenesis exhibited a diversity in envelopment
events. First, heterogeneous primary envelopment proﬁles were readily detectable at the
inner nuclear membrane of BoHV-1-infected cells. Second, the BoHV-1 progeny com-
prised not just full virions but also an abundance of capsidless, noninfectious light parti-
cles (L-particles) that were released from the infected cells in numbers similar to those of
virions and in the absence of DNA replication. Proteomic analysis of BoHV-1 L-particles
and the much less abundant HSV-1 L-particles revealed that they contained the same
complement of envelope proteins as virions but showed variations in tegument content.
In the case of HSV-1, the UL46 tegument protein was reproducibly found to be 6-fold
enriched in HSV-1 L-particles. More strikingly, the tegument proteins UL36, UL37, UL21,
and UL16 were depleted in BoHV-1 but not HSV-1 L-particles. We propose that these
combined differences reﬂect the presence of truly segregated “inner” and “outer” tegu-
ments in BoHV-1, making it a critical system for studying the structure and process of
tegumentation and envelopment.
IMPORTANCE The alphaherpesvirus family includes viruses that infect humans and ani-
mals. Hence, not only do they have a signiﬁcant impact on human health, but they also
have a substantial economic impact on the farming industry. While the pathogenic man-
ifestations of the individual viruses differ from host to host, their relative genetic com-
positions suggest similarity at the molecular level. This study provides a side-by-
side comparison of the particle outputs from the major human pathogen HSV-1 and
the veterinary pathogen BoHV-1. Ultrastructural and proteomic analyses have re-
vealed that both viruses have broadly similar morphogenesis proﬁles and infectious
virus compositions. However, the demonstration that BoHV-1 has the capacity to
generate vast numbers of capsidless enveloped particles that differ from those pro-
duced by HSV-1 in composition implies a divergence in the cell biology of these vi-
ruses that impacts our general understanding of alphaherpesvirus morphogenesis.
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The alphaherpesvirus subfamily comprises a group of complex viruses that includesimportant human and animal pathogens, such as herpes simplex virus 1 (HSV-1)
and bovine herpesvirus 1 (BoHV-1). Such viruses have a signiﬁcant impact on human or
animal health (1, 2) and in the case of agricultural infections can have a substantial
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economic impact (3, 4). Despite these viruses showing a diverse range of clinical
manifestations (5, 6), they show conservation in genome composition and virion
morphology (7, 8). The alphaherpesvirus particle consists of the DNA-containing capsid
surrounded by a proteinaceous layer known as the tegument, comprised of over 20
virus-encoded proteins and multiple cell proteins, which links the capsid with its host
membrane-derived envelope containing multiple virus-encoded glycoproteins (9, 10).
While studies on virion assembly have tended to center around HSV-1 and pseudora-
bies virus (PRV), there is growing interest in utilizing other alphaherpesviruses to
enhance our understanding of speciﬁc morphogenesis details that are still missing.
The currently favored model for assembly of the complex virion is termed the
envelopment-deenvelopment-reenvelopment model, in which capsids form in the
nucleus and bud through the inner nuclear membrane (INM) as a primary virion
(11–13). The virus-encoded machinery required for this envelopment, termed the
nuclear egress complex or NEC, consists of UL31 and UL34, considered to be the
tegument and envelope of the primary virion (14). This machinery is autonomous and
can function when expressed in isolation or even in vitro (15, 16). The primary envelope
is lost by fusion with the outer nuclear membrane (ONM), releasing naked capsids into
the cytosol (11, 12). This cytoplasmic capsid is subsequently enveloped in cellular
membranes together with the complement of tegument proteins to form the mature
virion.
The cellular location of alphaherpesvirus secondary envelopment has been a point
of contention for many years. For HSV-1 at least, in a model derived from ultrastructural
and Rab GTPase depletion studies, we have proposed that clathrin-mediated endocy-
tosis of tubules from the plasma membrane provides the main source of the HSV-1
envelope, with a concomitant cycling of virus envelope proteins through the plasma
membrane to the endocytic wrapping tubules (17). Virus egress would then result from
the natural recycling of these membranes to the cell surface. This model is in agree-
ment with previous studies from others (18) and has been supported by more recent
studies showing that glycoproteins must be transported to the plasma membrane prior
to envelopment taking place (19, 20).
One idiosyncratic feature of the alphaherpesvirus envelopment pathway that has
not been fully explored for understanding the molecular mechanisms involved in
envelopment is the production of noninfectious light particles (L-particles) that lack the
viral DNA-containing capsid but contain an enveloped tegument structure (21–26).
These L-particles could also help in understanding the process of tegumentation, i.e.,
where and when the numerous tegument proteins are recruited to the assembling
virion. Combinations of genetic and protein-protein interaction studies have led to the
concept of inner and outer tegument proteins, with inner tegument proteins (such as
UL36 and UL37) linking the capsid to the tegument and outer tegument proteins (such
as UL49) linking the tegument to the envelope (27). Inner tegument proteins would
hence be assembled onto the capsid at any point prior to envelopment, with some
evidence suggesting that UL36 may already be present on intranuclear capsids (28, 29).
While outer tegument proteins are proposed to be recruited to the envelope by
interactions with the cytoplasmic tails of glycoproteins, conclusive evidence for such
recruitment is still limited, with only two examples, UL11 and UL49, so far deﬁnitively
shown to be assembled in this way (30–33). This issue is further compounded by the
fact that many of the tegument proteins, even the major ones such as UL47 and UL49,
which are considered to be structurally important, are dispensable for virus growth and
therefore not required for virion formation (34–37). The assembly of tegument proteins
into L-particles may offer a different route to understanding the molecular interactions
that occur during alphaherpesvirus envelopment.
In this study, we employed a dual approach based on ultrastructural studies of
morphogenesis and virion proteomics to carry out comparative studies of HSV-1 and
BoHV-1 morphogenesis. We demonstrate that BoHV-1 assembly utilizes recently endo-
cytosed material for envelopment in a manner analogous to that of HSV-1, while
side-by-side proteomic analysis also conﬁrmed similar compositions for HSV-1 and
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BoHV-1 virions. BoHV-1 was seen to produce large numbers of capsidless L-particles
that were released in equivalent numbers to infectious virions. We report the ﬁrst
proteomic analysis of alphaherpesvirus L-particles indicating that the BoHV-1 but not
the HSV-1 L-particles were depleted for proteins that are commonly classiﬁed as part of
the inner tegument. These results reveal differences in the particle outputs from these
two viruses that make BoHV-1 L-particles a useful model with which to study tegu-
mentation and envelopment.
RESULTS
BoHV-1 capsids are wrapped in endocytic membranes. We have previously
shown that HSV-1 virions acquire their ﬁnal envelopes from glycoprotein-containing
endocytic tubular membranes that have been recently retrieved from the cytoplasmic
membrane, by using horseradish peroxide (HRP) to label ﬂuid-phase endocytic events
in infected cells (17). To investigate BoHV-1 envelopment, we therefore carried out the
same labeling of bovine MDBK cells, one of the few cell types in which BoHV-1
replicates, 12 h after infection at a multiplicity of 2. These studies revealed the presence
of many HRP-labeled endocytic tubules with a curved proﬁle in the cytoplasm (Fig. 1A
to C). These endocytic tubules frequently carried a budded terminal domain (Fig. 1B,
arrowheads), which had an indistinct peripheral coating when observed at higher
magniﬁcation (Fig. 1C, arrowheads), consistent with the appearance of clathrin coats, as
we have observed previously (17). Virus capsids were frequently found in tight asso-
ciation with these endocytic tubules in the cytoplasm of the infected cells (Fig. 1D to
H). Furthermore, many tubules that were associated with capsids retained the budded
terminal domain, consistent with a clathrin coat (Fig. 1G and H, arrowheads). Fully
enveloped virions wrapped in double membranes were detected in the cytoplasm (Fig.
1I), while particles enclosed in a single membrane were observed outside the cell,
consistent with our previous HSV-1 studies (Fig. 1J).
Comparative proteomic analysis of extracellular BoHV-1 and HSV-1 virions.We
next determined the relative protein contents of HSV-1 and BoHV-1 virions by isolating
extracellular virions from infected cultures of physiologically relevant cells, namely, the
HaCaT human keratinocyte cell line and the bovine epithelial MDBK cell line, respec-
tively. The virions were banded on a Ficoll gradient, and approximately equivalent
numbers of virions were solubilized and separated by SDS-PAGE, followed by staining
with Coomassie blue to conﬁrm the presence and purity of virions (Fig. 2A). Based on
their characteristic sizes and previous studies, several key components of virions were
identiﬁed, including the major capsid protein (VP5) and the tegument proteins UL36,
UL47, UL48, and UL49. Of note, all these proteins, with the exception of UL47, were
present at equivalent levels in both types of virions (Fig. 2A). In the case of UL47, in
BoHV-1, this protein (also known as VP8) is known to be packaged in unusually large
amounts (38). The BoHV-1 and HSV-1 virion proteins were subsequently separated by
SDS-PAGE and subjected to in-gel tryptic digestion, followed by fractionation using a
nanoscale high-performance liquid chromatography (nano-HPLC) system and tandem
mass spectrometry (MS/MS) to identify both virus and host cell proteins.
Using a conservative false discovery rate (FDR) of less than 1%, 51 virus and 488 host
cell proteins were identiﬁed in HSV-1 virions, and 51 virus and 883 host cell proteins
were identiﬁed in BoHV-1 (Fig. 2B). When considering those proteins predicted to be
conserved based on genome homology, the viral protein compositions of BoHV-1 and
HSV-1 virions were broadly similar, with 42 virus proteins identiﬁed in virions of both
viruses (Fig. 2C). Of the nine virus proteins that were uniquely identiﬁed in BoHV-1
virions, CIRC, US1.67, and UL3.5 can be accounted for by a lack of conservation of these
open reading frames within the HSV-1 genome. Likewise, ﬁve of the nine proteins
uniquely identiﬁed in HSV-1 virions are not conserved in the BoHV-1 genome (UL45,
UL55, UL56, US10, and US11). The full lists of virus proteins that were identiﬁed in HSV-1
and BoHV-1 virions are presented in Tables 1 and 2, respectively, organized according
to their proposed localization within the virion (8, 10), with a side-by-side comparison
provided in Table 3.
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The viral content of HSV-1 extracellular virions was very similar to that previously
reported by Loret and colleagues (10), conﬁrming the presence of four novel virion
components (UL7, UL23, UL50, and UL55) identiﬁed in that study, although we failed to
detect ICP34.5, which has also been characterized elsewhere as a virion component
(39). Likewise, the virus protein content of BoHV-1 virions was similar to that previously
reported by Barber and colleagues (8). We also identiﬁed 20 proteins in BoHV-1 virions
(Table 2) and 10 proteins in HSV-1 virions (Table 1) that were not identiﬁed in those
original studies (8, 10). The low protein score and poor peptide coverage of these
proteins suggest that they could be nonspeciﬁc, low-level contamination from cells
that had been picked up due to the increased sensitivity of mass spectrometry.
However, detection in virions from both the viruses and/or previous characterization of
these proteins as virion constituents suggests that at least some of them, such as US11
in HSV-1, are likely to be low-abundance constituents of the virion (40).
FIG 1 BoHV-1 capsids are wrapped in tubular endocytic membranes. MDBK cells were infected at a
multiplicity of infection (MOI) of 5 with BoHV-1, and HRP was added to the medium for 30 min at 12 h
postinfection (hpi). Samples were ﬁxed, processed, and imaged by transmission electron microscopy. White
arrows in panels B, C, G, and H indicate the budded terminal domains of endocytic tubules. Bars  500 nm
(B) and 200 nm (A and C to J).
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When considering those human host cell proteins for which there is a known bovine
homologue, only a quarter of the host cell proteins identiﬁed was shared between the
two viruses, variability which could be a consequence of isolating the virions from
different cell types (Fig. 2D). A selection of the proteins that were identiﬁed in both
BoHV-1 and HSV-1 virions is shown in Table 4, with the full list of host cell proteins
identiﬁed in BoHV-1 and HSV-1 virions presented Tables S1 and S2 and a comparison
presented in Table S3 in the supplemental material. While many of these proteins have
been previously identiﬁed within herpesvirus virions (8, 10, 41), the speciﬁcity of their
packaging remains to be determined. One potential explanation for the presence of so
many cell proteins in our preparations is that exosomes have been puriﬁed along
with our virions. While some exosomal markers (42) are present within our top cell
protein hits (annexin A2, coﬁlin, heat shock protein 70, and GAPDH [glyceraldehyde-
3-phosphate dehydrogenase]), it would be difﬁcult to say with conﬁdence that
exosomes are present. Moreover, because many of these proteins are known to be
among the most abundant proteins within the cell according to previously reported
protein abundance data (43), another interpretation of their presence is that their
recruitment is simply a reﬂection of local concentration at the site of envelopment
rather than speciﬁc incorporation into the virion. In light of this uncertainty, we have
not explored the packaging of cellular proteins further in this study.
A range of envelopment events in BoHV-1-infected cells. When examining
BoHV-1-infected MDBK cells by standard transmission electron microscopy (TEM), we
noted that these cells contained many more detectable primary envelopment events at
the inner nuclear membrane (INM) than we had found in our previous studies of
HSV-1-infected primary human ﬁbroblasts (17). Assembled capsids surrounded by a
distinct electron-dense primary envelope located in the perinuclear space between the
FIG 2 Puriﬁcation and proteomic characterization of extracellular HSV-1 and BoHV-1 virions. Conﬂuent monolayers of HaCaT
cells and MDBK cells were infected with HSV-1 and BoHV-1, respectively; at full cytopathic effect, cells were harvested; and
virions were isolated by separation on a 5 to 15% Ficoll gradient. (A) BoHV-1 and HSV-1 virions were separated by 10%
SDS-PAGE and stained with Coomassie blue. Size markers are shown in kilodaltons. (B) Summary of the numbers of proteins
identiﬁed in HSV-1 and BoHV-1 virions, at5% and1% FDRs. (C and D) Venn diagrams showing the overlap in virus proteins
(C) and host cell proteins (D) identiﬁed in HSV-1 and BoHV-1 virions.
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INM and the outer nuclear membrane (ONM) were frequently observed (Fig. 3A). These
primary virions either contained packaged DNA (Fig. 3A, top) or were empty of DNA
(Fig. 3A, bottom). Three budding events lacking DNA were readily identiﬁed: budding
of what appear to be B capsids (Fig. 3B, white arrow) and A capsids (Fig. 3B, white arrow
TABLE 1 Virus proteins detected in extracellularHSV-1 virionsa
aShown are virus proteins identiﬁed based on a 1% FDR. Location is based on that described by Loret et al. (10), and detection in that
previous study is indicated. The protein score reﬂects the number of peptides, abundance, and protein size to give a degree of
conﬁdence in protein identiﬁcation. Coverage is calculated based on peptides identiﬁed within each protein. A side-by-side comparison of
HSV-1 and BoHV-1 virions is presented in Table 3. Accession numbers were acquired from the UniProt human herpesvirus 1 (strain 17)
database (https://www.uniprot.org/proteomes/UP000009294).
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with black outline) and membrane budding in the complete absence of a capsid
(Fig. 3B, black arrows). Despite variations in cargo, each budding event involved
similar INM curvatures, producing perinuclear vesicles of comparable diameters, and all
events displayed an electron-dense coating on the inside surface of the curved
TABLE 2 Virus proteins detected in extracellular BoHV-1 virionsa
aVirus proteins were identiﬁed based on a 1% FDR. Location is based on that described by Barber et al. (8) or as expected based on the
localization of homologous HSV-1 proteins, and detection in that previous study is indicated. The protein score reﬂects the number of peptides,
abundance, and protein size to give a degree of conﬁdence in protein identiﬁcation. Coverage is calculated based on peptides identiﬁed within
each protein. A side-by-side comparison of HSV-1 and BoHV-1 virions is presented in Table 3. Accession numbers were acquired from the
UniProt bovine herpesvirus 1 (strain K22) database (https://www.uniprot.org/proteomes/UP000170085).
Comparative Morphogenesis Studies of HSV-1 and BoHV-1 Journal of Virology
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membrane. These observations suggest that capsid association with the INM does not
regulate budding of the INM in BoHV-1-infected cells and that, as is known for HSV-1
and PRV, scission of the budded INM is an autonomous process that can occur
efﬁciently in the absence of a capsid cargo (16).
In addition to capsidless budding at the INM, we were also able to identify
surprisingly large numbers of capsidless light particles (L-particles) within the cyto-
TABLE 3 Comparison of BoHV-1 and HSV-1 virion compositionsa
aShown is a side-by-side comparison of BoHV-1 and HSV-1 virion compositions based on data presented in Tables 1 and 2 for HSV-1 and
BoHV-1 homologues.
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plasm (Fig. 3C). These particles were of the same diameter as full virions, were wrapped
in a double membrane, and contained electron-dense material that is likely to be
tegument (Fig. 3C). Moreover, the extracellular population of released particles con-
tained a high proportion of capsidless L-particles (Fig. 3D), which when measured for
two strains of BoHV-1 amounted to around 50% of all released particles (Fig. 3E). In
comparison, we found approximately 2% capsidless L-particles in similar electron
micrographs of HSV-1-infected cells (not shown).
BoHV-1 particle assembly proceeds in the absence of DNA replication. Since
both nuclear budding and particle egress can occur in the absence of a capsid cargo,
we reasoned that, as for HSV-1 (24), both stages would be detectable in the absence of
DNA replication. To examine this, BoHV-1 infection was perturbed by treatment with
the nucleoside analogue arabinofuranosyl cytidine (AraC). AraC effectively blocked
BoHV-1 genome replication as measured by semiquantitative PCR (Fig. 4A), while the
late protein UL47 (VP8) was expressed albeit at lower levels than in untreated cells (Fig.
4B). TEM analysis of AraC-treated infected cells revealed a variety of budding events at
the inner nuclear membrane, including incomplete budding through the INM (Fig. 4C
and D) as well as fully formed perinuclear vesicles (Fig. 4E). A small number of these
vesicles contained B capsids (Fig. 4E, white arrowhead), but the majority of them were
empty, conﬁrming that INM budding proceeds even when prior steps of virus assembly
have not taken place.
TABLE 4 A subset of host cell proteins detected in extracellular HSV-1 and BoHV-1 virionsa
aShown are host cell proteins identiﬁed based on a 1% FDR. The protein score reﬂects the number of peptides, abundance, and protein
size to give a degree of conﬁdence in protein identiﬁcation. Data sets are shown in full in Tables S1 to S3 in the supplemental material.
Accession numbers were acquired from the UniProt human and Bos taurus databases (https://www.uniprot.org/proteomes/UP000005640
and https://www.uniprot.org/proteomes/UP000009136).
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In addition to nuclear budding, cytoplasmic membranes that had a degree of
curvature similar to that observed in infection of untreated cells were identiﬁed (Fig. 4F
and G). Although capsids were not associated with these membranes, their curvature
and size were such that capsids could be accommodated. Electron-dense material was
seen to be associated with some of these endocytic membranes, which may represent
assembling tegument (Fig. 4F and G, black arrows). Densely packed clusters of capsid-
less particles with consistent diameters were also noted outside the infected cells (Fig.
4H), and these particles had apparent glycoprotein spikes on their surface (Fig. 4I). These
electron micrographs indicate that particle production continued efﬁciently in the absence
FIG 3 A variety of wrapping events occur in BoHV-1-infected cells. MDBK cells were infected at an MOI of 5 with BoHV-1 and
ﬁxed and processed for transmission electron microscopy at 12 hpi. (A and B) Representative sections of the nuclear envelope.
In panel B, nuclear budding proﬁles that contain capsids resembling B capsids (white arrow) and A capsids (white arrow with
black outline) or those occurring without a capsid (black arrows) are indicated. Bar  200 nm. INM, inner nuclear membrane;
ONM, outer nuclear membrane. (C) Fully wrapped capsidless L-particles were detected in the cytoplasm. Bar  100 nm. (D)
Multiple extracellular particles included full virions and capsidless L-particles. Bar  500 nm. (E) Extracellular particles of MDBK
cells infected with two strains of BoHV-1 were scored for the presence or absence of a capsid. Wt, wild type.
Russell et al. Journal of Virology
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FIG 4 Inhibition of DNA replication with AraC does not arrest alternative wrapping events. (A and B) MDBK cells
were infected at an MOI of 5 with BoHV-1 in the absence or presence of 100 g/ml AraC. (A) The level of BoHV-1
genomic DNA was measured at 16 h by semiquantitative PCR using primers speciﬁc for UL47. (B) Synthesis of the
late VP8 protein was measured by Western blotting of samples harvested at the indicated times. Un, uninfected.
(C to I) MDBK cells were infected at an MOI of 5 with BoHV-1 in the presence of 100 g/ml AraC. Samples were
ﬁxed and processed at 16 h, before processing for transmission electron microscopy. (C and D) Incomplete budding
through the INM in the direction of the perinuclear space. (E) Several sealed vesicles are shown in the perinuclear
(Continued on next page)
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of BoHV-1 DNA replication, and we predict that these particles are L-particles enveloped via
the normal envelopment route in the absence of capsid production. A one-step growth
curve carried out in the absence or presence of AraC also conﬁrmed that no infectious
particles were produced under these conditions (Fig. 4J).
Proteomic composition of L-particles generated during BoHV-1 and HSV-1
infection. To characterize the relative composition of BoHV-1 L-particles in comparison
to virions, the upper (light) and lower (virion) bands on a Ficoll gradient (Fig. 5A) were
harvested by needle puncture through the side of the tube and analyzed by SDS-PAGE,
followed by staining with Coomassie blue (Fig. 5B). As before, bands corresponding to
the sizes expected for several characteristic virus proteins were identiﬁed, with a band
corresponding to the major capsid protein (VP5) detectable in virions but barely
detectable in L-particles, suggesting negligible contamination of this sample with
virions. Many of the proteins were present at similar levels in both samples, but at least
ﬁve proteins were identiﬁed as being differentially packaged into virions, as indicated
by black dots (Fig. 5B). While several of these are likely to be capsid proteins, at least
one of them, UL36, is a known inner tegument protein. To compare the composition of
L-particles to that of virions in greater detail, a duplex tandem mass tagging (TMT)
system was used to label L-particle and virion samples, and mass spectrometry was
used to identify and quantify the different proteins present in these samples (44). Initial
analysis of the raw data indicated that, as expected, the L-particle/virion ratios of each
virus glycoprotein were similar and ranged from 1 to 1.6 (Table 5). Therefore, to
facilitate the subsequent analysis of the total data set, the light particle/virion ratios of
all glycoproteins were averaged, and all light particle/virion ratios were normalized to
this value. The results are summarized according to their predicted location in the
envelope, tegument, or capsid (Fig. 5C), with total protein scores provided in Table 5.
This shows that while envelope proteins were roughly equally abundant in the two
populations, and the abundances of most of the proteins classiﬁed as capsid proteins
were greatly reduced in L-particles, the BoHV-1 tegument proteins segregated into two
groups: those that behaved like capsid proteins and were found mainly within virions
and those that were equally as or more abundant within L-particles.
The ratios of individual proteins have been further grouped according to their
predicted location within the virion and ranked according to the number of unique
peptides identiﬁed for each of them (Fig. 5D). As also shown in Fig. 5C, the individual
envelope proteins are tightly grouped around the normalization line (Fig. 5D). In
contrast, the abundances of the capsid proteins UL19, UL25, UL26, and UL35 were
greatly reduced in the L-particle samples (Fig. 5D). Interestingly, the UL17 protein was
the most abundant capsid protein in the BoHV-1 L-particles, in agreement with a
previous study showing UL17 as a component of both the tegument and capsid of
HSV-1 (45). Among the tegument proteins, those that segregated with virions included
the known inner tegument proteins UL36 and UL37 (Fig. 5D). Additionally, UL48, UL21,
UL16, and UL3.5 proteins also appeared to be depleted from the L-particle samples. It
should be noted that the results for those proteins to the right-hand side of each
section of Fig. 5D (for example, the UL6 capsid protein and BICP22 in the tegument)
should be treated with caution because of their low protein score and number of
unique peptides identiﬁed (Fig. 5D). Nonetheless, the high protein scores for the more
abundant tegument proteins provide conﬁdence in the analysis, and taken together,
this would suggest that each of the inner tegument proteins that is predicted to link
the virus capsid to the tegument in the virion is barely present within our L-particle
FIG 4 Legend (Continued)
space, with the arrow indicating a vesicle containing a B capsid. (F and G) Curved cytoplasmic tubules within the
cytoplasm, frequently in association with electron-dense aggregates of material, indicated by the black arrows. (H
and I) Extracellular space immediately adjacent to the plasma membrane, showing electron-dense particles,
without a capsid cargo. Bars  200 nm (C to G and I) and 2 m (H). (J) MDBK cells were infected at an MOI of 5
with BoHV-1 in the absence (AraC) or presence (AraC) of 100 g/ml AraC. Total virus was harvested at the
indicated times and titrated on MDBK cells. Data from three biological replicates under each condition are shown.
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FIG 5 Quantitative proteomic comparison of the L-particles and virions produced during BoHV-1 infection. (A) Conﬂuent monolayers of MDBK
cells were infected with BoHV-1 strain P8-2, and HaCaT cells were infected with HSV-1 strain Sc16, both at a multiplicity of 0.02. At full cytopathic
effect, the extracellular medium was harvested, and released particles were isolated on 5% to 15% Ficoll gradients. Representative Ficoll gradients
of BoHV-1 and HSV-1 particle preparations isolated at the same time are shown. (B) Equal amounts of the virion (V) and L-particle (L) bands of
BoHV-1 were separated by 10% SDS-PAGE and stained with Coomassie blue. Black dots denote protein bands present in virions but not L-particles.
Size markers are shown in kilodaltons. (C) The BoHV-1 virion and L-particle samples were subjected to TMT labeling and analyzed by mass
spectrometry. Shown is a summary of the normalized ratios of virus proteins detected in BoHV-1 L-particles to virions, grouped according to their
predicted location within the virion. The normalization line represents the average of all glycoprotein ratios, with 1 standard deviation on either
side represented by dotted lines. (D) Ratio of individual virus proteins in BoHV-1 L-particles compared to virions (top), in order of the number of
unique peptides detected (bottom). The dashed red line is the glycoprotein normalization line.
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preparation. In short, BoHV-1 L-particles appear to be assembled without the inner
tegument-capsid-interacting proteins.
Although we have found that HSV-1 L-particles were much less abundant in
extracellular puriﬁed particle populations from HaCaT cells than BoHV-1 from MDBK
cells (Fig. 5A), we harvested the equivalent regions of the HSV-1 gradient as we had for
the BoHV-1 gradient, which enabled us to isolate a small number of HSV-1 L-particles
for proteomic analysis as described above for BoHV-1. In contrast to BoHV-1, most
HSV-1 tegument proteins appeared to be largely equally abundant in virions and
L-particles (Fig. 6A and B; total protein scores are provided in Table 6). In particular,
further analysis revealed that unlike BoHV-1, the inner tegument proteins of HSV-1 were
abundant in L-particles (Fig. 6A), as has been shown by others (22). Interestingly, UL46
(VP11/12) and US11 were enriched around 6-fold and 4-fold, respectively, in
L-particles, and UL50 was enriched to a lesser extent, 2-fold (Fig. 6A).
Because the HSV-1 L-particles were difﬁcult to isolate, and to ensure that this
enhanced incorporation was reproducible, a second isolation of HSV-1 virions and
L-particles was carried out and analyzed by TMT mass spectrometry. This conﬁrmed
that the tegument proteins were all approximately equally abundant in HSV-1
L-particles and virions, again with the exception of UL46 and US11 (Fig. 6C). However,
on this occasion, UL50 was undetectable in the samples, while ICP0 was detected in the
second but not the ﬁrst preparation. This showed that, as for BoHV-1, variability in the
TABLE 5 Results of TMT proteomic analysis of BoHV-1 L-particles and virionsa
aBoHV-1 proteins were identiﬁed based on a 1% FDR, with the L-particle-to-virion ratio for each protein shown.
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FIG 6 Quantitative proteomic comparison of the L-particles and virions produced in HSV-1 infection. (A) A Ficoll gradient for HSV-1 strain
Sc16 similar to that shown in Fig. 5A was harvested for virions and L-particles as for BoHV-1 and analyzed by tandem mass tag labeling
mass spectrometry as for BoHV-1. The results are presented as the ratio of the number of individual virus proteins in HSV-1 L-particles to
virions (top), in order of the number of unique peptides detected (bottom). The dashed red line is the glycoprotein normalization line.
(B) Summary of the normalized ratios of virus proteins detected in HSV-1 L-particles to virions, grouped according to their predicted
(Continued on next page)
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content of proteins detected by low peptide numbers could not provide conﬁdence in
the results to the extreme right-hand side of the graph. To further validate these
proteomic results, approximately equivalent numbers of a third preparation of HSV-1
L-particles and virions, as judged by Coomassie blue staining (Fig. 6D), were analyzed
by Western blotting for the presence of a range of virus proteins, as indicated (Fig. 6E).
As predicted from the mass spectrometry analysis, gD, VP22, and VP16 were similarly
abundant in L-particles and virions, while the major capsid protein VP5 encoded by
UL19 was enriched in the virion sample. In contrast, both UL46 and US11 were enriched
in the L-particle sample, conﬁrming the results of the mass spectrometry analysis (Fig.
6E). Of note, Western blotting of virions and L-particles for ICP34.5 failed to detect this
protein despite a strong positive blot from infected cell lysates (data not shown). While
we cannot exclude the possibility that the differences found in L-particle content
between BoHV-1 and HSV1 were a consequence of the cell types used to purify the
particles, these data highlight the fact that there are virus-speciﬁc variations in the
makeup of noninfectious L-particles.
DISCUSSION
In this study, we have extended our previous studies on HSV-1 morphogenesis (17)
to provide evidence that BoHV-1 may follow a pathway similar to that of HSV-1. In
ultrastructural studies, BoHV-1 wrapping events were similar to those previously found
for HSV-1, with capsids associating with curved tubules which were positive for HRP
that had been taken up by ﬂuid-phase endocytosis. Given the growing evidence for the
role of endocytosis at the molecular and ultrastructural levels for a range of herpesvi-
ruses (17, 20, 46–48), we propose that this model, which requires virus glycoproteins to
ﬁrst trafﬁc to the plasma membrane before being retrieved into the endocytic mem-
branes, may represent a unifying model of alphaherpesvirus envelopment. Many of the
endocytic tubules found in the cytoplasm of BoHV-1-infected cells exhibited a repro-
ducible membrane curvature and contained budded domains, with the diameter,
density, and structure bearing strong similarities to those of endocytic clathrin coats
previously reported in uninfected cells (49). The presence of clathrin-like coats has also
been reported in cryo-electron microscopy (EM)-based studies of HSV-1 envelopment
(17, 26). Similarly, our studies have shown that BoHV-1 exhibits the same primary
envelopment proﬁles, budding at the INM and within the perinuclear space, that have
been identiﬁed for several other herpesviruses, including HSV-1 and PRV (13). However,
compared to our previous results with HSV-1, these proﬁles were numerous and readily
detectable in BoHV-1-infected cells, indicating that these events occur either more
frequently or more slowly than in HSV-1. In addition to ultrastructural studies, we have
also carried out the ﬁrst side-by-side proteomic study of HSV-1 and BoHV-1 virions, both
of which have been previously characterized independently by mass spectrometry (8,
10). In general, our results are in agreement with those previous studies, despite
differences in strains of virus and cell lines used to produce the extracellular virions and
conﬁrm that the complements of virus-encoded proteins packaged into virions are
similar for both viruses. In the case of HSV-1, we conﬁrmed the absence of glycopro-
teins UL43, gJ, and gN but were able to detect two glycoproteins, gK and UL45, that had
not been previously identiﬁed in its proteome. In BoHV-1, we detected 20 more virion
proteins than in the previous study, including several proteins that were also present
in HSV-1 virions. Glycoprotein G, encoded by US4, was found to be highly abundant in
BoHV-1 virions but hardly detectable in HSV-1 virions. Nevertheless, it is important to
consider than many of these constituents had mass spectrometry scores lower than
FIG 6 Legend (Continued)
location within the virion. The normalization line represents the average of all glycoprotein ratios, with 1 standard deviation on either side
represented by dotted lines. (C) Comparative ratios of individual tegument proteins between two independent TMT labeling analyses. (D
and E) Approximately equivalent amounts of Sc16 virions (V) and L-particles (L) were subjected to SDS-PAGE on a 10% polyacrylamide
gel followed by Coomassie blue staining (D) or Western blotting (E) for the indicated virus proteins. Approximately equivalent numbers
of particles were loaded by equating gD and UL48 by Western blotting. Molecular weight markers are shown in kilodaltons.
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that for the portal protein UL6, which is known to be present in just 12 copies in each
virion. While protein score is not a direct readout of protein abundance in the sample,
it is an indication that these proteins were difﬁcult to detect in the virion samples. There
are a number of potential explanations for this: (i) they are present in very low copy
numbers in each particle, (ii) they are present in vastly variable numbers between
particles, or (iii) they are simply contaminants from the cell extract that had been
detected by the increased sensitivity of mass spectrometry. For example, the UL34
component of the NEC was detected at very low levels in particles from both viruses,
TABLE 6 Results of TMT proteomic analysis of HSV-1 L-particles and virionsa
aShown are HSV-1 proteins identiﬁed based on a 1% FDR, with the L-particle-to-virion ratio for each protein shown.
Comparative Morphogenesis Studies of HSV-1 and BoHV-1 Journal of Virology
November 2018 Volume 92 Issue 22 e01259-18 jvi.asm.org 17
 o
n
 N
ovem
ber 21, 2018 by guest
http://jvi.asm.org/
D
ow
nloaded from
 
but given its role at the nuclear membrane, it may not be expected to be incorporated
into the mature particle. In addition, while the presence of glycoprotein K was con-
vincing in both viruses, the level of its partner glycoprotein UL20 was extremely low (50,
51). Finally, despite the increased sensitivity of our mass spectrometry analysis, we
failed to identify either ICP34.5 or US9 in HSV-1 virions, both of which had been
detected by only a single peptide in the previous proteomic study on HSV-1 (10).
We found that in BoHV-1-infected cells, the capsidless envelopment events occurred
with great efﬁciency. As a consequence, we were able to isolate released L-particles and
compare their composition to that of BoHV-1 virions by mass spectrometry. Intrigu-
ingly, this revealed that the BoHV-1 L-particles, although not retrieved as a completely
homogeneous population free of contaminating virions, were depleted for UL36, UL37,
and UL48, essential tegument proteins that link the capsid to the tegument/envelope
structure of alphaherpesviruses (27). Three other tegument proteins, UL21, UL16, and
UL3.5, were also notable for being depleted from the BoHV-1 L-particles. UL21 has been
shown to be involved in nuclear egress of HSV-1 and HSV-2 capsids (52, 53), suggesting
a potential role in bridging the capsid to the envelope. Likewise, UL16 has been shown
to be required for the egress of HSV-2 capsids from the nucleus (54) but has not been
designated this role in HSV-1, where deletion of UL16 has a limited effect on virus
replication (55). Interestingly, a recent study from the Banﬁeld group has shown that
HSV-1 UL16 rescues the nuclear egress defect in the HSV-2 knockout virus, suggesting
that HSV-1 has another factor absent from HSV-2 that fulﬁls this role in the absence of
UL16 (56). In light of this, it is important to note that as for HSV-2, BoHV-1 UL16 is
essential for BoHV-1 replication (57). Finally, the UL3.5 protein is not present in HSV-1,
but for BoHV-1, it has been shown to interact with UL48 (58), an interaction which might
also place it within the inner tegument. Taken together with the high abundance of
these particles, and the fact that they were efﬁciently produced in the absence of DNA
replication, we propose that BoHV-1 L-particles lack the inner tegument, represent
enveloped outer tegument proteins, and are produced in an event that is autonomous
and entirely independent of steps prior to ﬁnal wrapping in the assembly pathway. In
support of this, studies on other viruses have shown that L-particles are produced in the
absence of DNA replication, DNA packaging, or delivery of capsids to the cytoplasm (24,
59, 60), indicating that at least some of the proteins that make up L-particles are
sufﬁcient to direct the envelopment process (22). Moreover, the fact that the comple-
ments of outer tegument proteins are similar in full virions and L-particles would
suggest that they share the same morphogenesis and release pathway, in agreement
with data from other studies on PRV (61).
In contrast, in our hands, HSV-1 L-particles were released from human keratinocytes
in much lower numbers. While we recognize that the level of L-particle production
appears to be cell type dependent for HSV-1 (62), our result in HaCaT cells is in
agreement with our previous experience of isolating HSV-1 particles from both BHK21
and Vero cells, where we consistently recover large numbers of infectious virions but
few observable L-particles, as illustrated in Fig. 5A. Unfortunately, it is not possible to
compare the two viruses in the same cell line, as BoHV-1 is restricted in its host range,
while, consistent with previous studies (63, 64), we have been unable to isolate HSV-1
particles from MDBK cells. Nonetheless, two replicate preparations of HSV-1 L-particles
from HaCaT cells revealed that unlike BoHV-1, the inner tegument proteins were
incorporated into HSV-1 L-particles to approximately the same level as in virions.
Interestingly, the UL46 tegument protein was reproducibly enhanced around 5-fold in
HSV-1 L-particles compared to virions, a feature that may provide clues to the HSV-1
L-particle assembly-and-trafﬁcking pathway. In relation to this, the biological signiﬁ-
cance of L-particles remains unknown, but as suggested by others (65), it is tempting
to speculate that BoHV-1 L-particles in particular could deliver large amounts of outer
tegument proteins to uninfected cells ahead of or as an enhancement to infecting virus.
As it is now becoming clear that many of these proteins may have roles in counter-
acting cellular antiviral responses (66), the initial infected cell could potentially send out
a wave of these particles to either deliver proteins that can ﬁght a preexisting antiviral
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state set up by interferons or prevent responses induced by subsequent incoming
infection. It is therefore interesting to note that HSV-1 UL46 has recently been assigned
a role in evading the STING-cGAS DNA-sensing pathway (67), while BoHV-1 UL47 is
proposed to inhibit interferon signaling by binding to STAT1 (68).
In summary, the abundance and tractability of BoHV-1 L-particle production make
this system particularly attractive to further our understanding of virus morphogenesis
and the role of tegument proteins. Moreover, the potential therapeutic application of
these noninfectious particles, such as vaccine development or the packaging and
delivery of heterologous overexpressed proteins, is a much more realistic prospect
given a system that is exquisitely designed to produce these particles efﬁciently and in
large amounts.
MATERIALS AND METHODS
Cells and viruses. Vero cells were cultured in Dulbecco’s modiﬁed Eagle medium (DMEM) supple-
mented with 10% newborn calf serum (NCS) and 50 U/ml penicillin-streptomycin. HaCaT and MDBK cells
were cultured in DMEM supplemented with 10% fetal bovine serum and 50 U/ml penicillin-streptomycin.
HSV-1 strain Sc16 was routinely propagated and titrated in Vero cells in DMEM supplemented with 2%
NCS and 50 U/ml penicillin-streptomycin. BoHV-1 strains P8-2 and r115 were routinely propagated and
titrated in MDBK cells in DMEM supplemented with 2% NCS and 50 U/ml penicillin-streptomycin.
Isolation of extracellular virus particles. For mass spectrometry-based studies, released HSV-1 and
BoHV-1 virions and L-particles were gradient puriﬁed as described previously (69). Brieﬂy, 10 175-cm2
ﬂasks of conﬂuent MDBK or HaCaT cells (approximately 6  108 cells in total) were infected with BoHV-1
(strain P8-2) or HSV-1 (strain Sc16) at a multiplicity of 0.02. Once cytopathic effect was advanced (3 to 4
days postinfection), the extracellular medium was collected and centrifuged at 3,000 rpm for 30 min at
4°C in a ﬁxed-angle rotor to remove cell debris. Virus particles were then pelleted from the cleared
supernatant at 9,000 rpm for 90 min at 4°C. The particle pellet was resuspended in 0.5 ml phosphate-
buffered saline (PBS) and carefully layered onto a preformed 11-ml 5% to 15% (wt/vol) Ficoll gradient in
a 13.2-ml thin-wall polyallomer ultracentrifuge tube (Beckman Coulter). Gradients were centrifuged at
12,000 rpm for 2 h at 4°C in an SW41 Ti swinging-bucket rotor in a Sorvall Discovery SE ultracentrifuge.
Light and heavy bands were harvested by needle puncture through the side of the tube with a 19-gauge
hypodermic needle in a volume of 1 ml, diluted in 10 ml PBS, and pelleted at 25,000 rpm for 1 h at 4°C
using the same rotor and ultracentrifuge. The pellets were resuspended in a suitable volume of PBS and
stored at 80°C.
SDS-PAGE and Western blotting. Virus particle samples were separated by 9 or 10% SDS-PAGE and
stained with Coomassie blue or transferred to nitrocellulose membranes before Western blotting. The
following primary antibodies were used for Western blots and kindly provided: mouse anti-gD (LP14),
from Tony Minson (University of Cambridge); mouse anti-VP16 (LP1), from Colin Crump (University of
Cambridge); rabbit anti-UL46, from Richard Courtney (Pennsylvania State University); rabbit anti-US11,
from Ian Mohr (New York University); and mouse anti-VP5 (HA-018; Virusys). Our rabbit VP22-speciﬁc
antibody (AGV031) has been described previously (70, 71). Goat anti-mouse IRDye 680RD and goat
anti-rabbit IRDye 800CW (Li-Cor Biosciences) secondary antibodies were used as appropriate, before
blots were imaged using an Odyssey CLx imaging system (Li-Cor Biosciences).
Conventional proteomic analysis of BoHV-1 and HSV-1 virions. BoHV-1 or HSV-1 virion samples
were separated by SDS-PAGE, the gel lane was cut into three slices, and each slice was subjected to in-gel
tryptic digestion using a DigestPro automated digestion unit (Intavis). The resulting peptides were
fractionated using a nano-HPLC system with an LTQ-Orbitrap Velos mass spectrometer (ThermoFisher
Scientiﬁc).
TMT proteomic analysis of BoHV-1 and HSV-1 L-particles and virions. A total of 100 g of protein
was digested with 2.5 g trypsin overnight at 37°C and labeled with tandem mass tag (TMT) sixplex
reagents according to the manufacturer’s protocol (ThermoFisher Scientiﬁc). The virion and L-particle
samples were then pooled, evaporated to dryness, resuspended in 5% (vol/vol) formic acid, and then
desalted using Sep-Pak cartridges according to the manufacturer’s instructions (Waters). The eluent from
the Sep-Pak cartridge was evaporated to dryness and resuspended in 1% (vol/vol) formic acid before
analysis by the nano-HPLC system with an Orbitrap Fusion Tribrid mass spectrometer (ThermoFisher
Scientiﬁc).
Nano-HPLC mass spectrometry. Samples were fractionated using an Ultimate 3000 nano-HPLC
system. In brief, peptides in 1% (vol/vol) formic acid were injected onto an Acclaim PepMap C18
nano-trap column (ThermoFisher Scientiﬁc). After washing with 0.5% (vol/vol) acetonitrile–0.1% (vol/vol)
formic acid, peptides were resolved on a 250-mm by 75-m Acclaim PepMap C18 reverse-phase analytical
column (ThermoFisher Scientiﬁc) over a 150-min organic gradient, using seven gradient samples for
conventional samples (1 to 6% solvent B [aqueous 80% {vol/vol} acetonitrile in 0.1% {vol/vol} formic acid]
over 1 min, 6 to 15% solvent B over 58 min, 15 to 32% solvent B over 58 min, 32 to 40% solvent B over
5 min, and 40 to 90% solvent B for 6 min, which was then reduced to 1% solvent B over 1 min) or six
gradient segments for TMT-labeled samples (5 to 9% solvent B over 2 min, 9 to 25% solvent B over 94
min, 25 to 60% solvent B over 23 min, and 60 to 90% solvent B over 5 min, which was held at 90% solvent
B for 5 min and then reduced to 1% solvent B over 2 min), with a ﬂow rate of 300 nl min1. Peptides were
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ionized by nano-electrospray ionization at 2.0 or 2.1 kV using a stainless steel emitter with an internal
diameter of 30 m (ThermoFisher Scientiﬁc) and a capillary temperature of 275°C.
For conventional proteomics, tandem mass spectra were acquired using an LTQ-Orbitrap Velos mass
spectrometer controlled by Xcalibur 2.1 software (ThermoFisher Scientiﬁc) and operated in the data-
dependent acquisition mode. The Orbitrap was set to analyze the survey scans at a 60,000 resolution (at
m/z 400) in the mass range m/z 300 to 2,000, and the top 20 multiply charged ions in each duty cycle
were selected for tandem mass spectrometry (MS/MS) in the LTQ linear ion trap. Charge-state ﬁltering,
where unassigned precursor ions were not selected for fragmentation, and dynamic exclusion (repeat
count, 1; repeat duration, 30 s; exclusion list size, 500) were used. Fragmentation conditions in the LTQ
instrument were as follows: normalized collision energy of 40%, activation q of 0.25, activation time of
10 ms, and minimum ion selection intensity of 500 counts.
For TMT-labeled samples, all spectra were acquired by using an Orbitrap Fusion Tribrid mass
spectrometer controlled by Xcalibur 2.0 software (ThermoFisher Scientiﬁc) and operated in the data-
dependent acquisition mode using an SPS-MS3 workﬂow. FTMS1 spectra were collected at a resolution
of 120,000, with an automatic gain control target of 400,000 and a maximum injection time of 100 ms.
Precursors were ﬁltered with an intensity range from 5,000 to 1  1020, according to charge state (to
include charge states 2 to 6), and with monoisotopic precursor selection. Previously interrogated
precursors were excluded using a dynamic window (60 s  10 ppm). The MS2 precursors were isolated
with a quadrupole mass ﬁlter set to a width of 1.2 m/z. ITMS2 spectra were collected with an AGC target
of 10,000, a maximum injection time of 70 ms, and CID collision energy of 35%.
For FTMS3 analysis, the Orbitrap was operated at a 30,000 resolution with an AGC target of
50,000 and a maximum injection time of 105 ms. Precursors were fragmented by high-energy
collision dissociation at a normalized collision energy of 55% to measure maximal TMT reporter ion
yield. Synchronous precursor selection was enabled to include up to ﬁve MS2 fragment ions in the
FTMS3 scan.
Proteomic data analysis. The raw data ﬁles were processed and quantiﬁed using Proteome
Discoverer software v1.4 (ThermoFisher Scientiﬁc). The data were searched against either the UniProt
human database (downloaded on 18 April 2016; 134,169 entries) and the UniProt human herpesvirus 1
(strain 17) database (downloaded on 11 April 2016; 73 entries) or the UniProt Bos taurus database
(downloaded on 21 October 2016; 31,855 entries) and the UniProt bovine herpesvirus 1 (strain K22)
database (downloaded on 21 October 2016; 69 entries) as appropriate. All searches were performed
using the SEQUEST algorithm. The peptide precursor mass tolerance was set at 10 ppm, and the MS/MS
tolerance was set at 0.8 or 0.6 Da. Search criteria included oxidation of methionine (15.9949) as a
variable modiﬁcation and carbamidomethylation of cysteine (57.0214) and the addition of the TMT
mass tag (229.163) to peptide N termini and lysine as ﬁxed modiﬁcations. Searches were performed
with full tryptic digestion, and a maximum of one missed cleavage was allowed. The reverse database
search option was enabled, and all peptide data were ﬁltered to satisfy a false discovery rate (FDR) of 5%
or 1%.
Transmission electron microscopy. To prepare samples for electron microscopy, cells were grown
to conﬂuence overnight before infection with virus. When infection was carried out in the presence of
AraC, all infection, washing, and incubation steps were performed in the presence of 100 ng/ml AraC.
Horseradish peroxidase (HRP) labeling was performed as previously described (17), by incubating cells
with 10 mg/ml HRP for 30 min prior to ﬁxation. After ﬁxation, samples were washed and stained with a
metal-enhanced 3,3=-diaminobenzidine (DAB) substrate kit (ThermoFisher Scientiﬁc). The samples for
electron microscopy were ﬁxed and processed as previously described (72).
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